| Previous Close | 1.4 |
| Open | 1.41 |
| Day High | 1.42 |
| Day Low | 1.38 |
| 52-Week High | 1.6 |
| 52-Week Low | 0.98 |
| Volume | 1.77M |
| Average Volume | 2.58M |
| Market Cap | 1.05B |
| PE | -5.15 |
| EPS | -0.27 |
| Moving Average 50 Days | 1.24 |
| Moving Average 200 Days | 1.31 |
| Change | -0.01 |
OPKO Health to Participate in the Jefferies Biotech on the Beach Summit
GlobeNewswire Inc.
Feb 27, 2026 1:00 PM GMT
MIAMI, Feb. 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Biotech on the Beach Summit, being held March 10-11, 2026, at 1 Hotel South Beach in Miami. Management w
OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26
GlobeNewswire Inc.
Feb 12, 2026 1:00 PM GMT
MIAMI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and 12 months ended December 31, 2025, after the close of the U.S. financial markets on Thursday, February 26, 20
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism
GlobeNewswire Inc.
Feb 04, 2026 1:00 PM GMT
This is the third program that successfully combines Entera’s oral peptide N-Tab® platform with OPKO’s advanced protein chemistry capabilities The companies have accelerated this program and aim to file an investigational new drug (IND) application i